drug discovery

A unique collection of 2860 approved drugs for high throughput screening (HTS) and high content screening (HCS);

3280 compounds from marketed drugs for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 610 compounds targeting PI3K/Akt/mTOR signaling for research in PI3K/Akt/mTOR signaling, and drug discovery in diseases involved with PI3K/Akt/mTOR signaling;

A unique collection of 2400 GPCR-active agents for high throughput screening and high content screening for GPCR drug discovery, and new GPCR target identification and research;

A unique collection of 2955 kinase inhibitors/regulators for high throughput screening and high content screening for drug discovery in kinase related diseases;

A unique collection of 263 kinase inhibitors/regulators for specific targeting of kinases, ready for high-throughput screening and high-content screening.

A unique collection of 1385 anti-virus compounds effective for new anti-virus drugs high throughput screening and high content screening;

A unique collection of 3230 anticancer drugs for high throughput screening (HTS) and high content screening (HCS);

Well-chosen quantity: only contains 989 bioactive compounds after careful selection

A unique collection of 1855 FDA approved drugs for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 425 antifungal compounds effective for drug repurposing screening, combination screening and biological investigation.

A unique collection of 4607 pure natural products and their derivatives with known biological activity for drug discovery, pharmacological study, stem cell differentiation, fingerprint study and quality research, and can be used for high throughput screen

A unique collection of 4221 natural products for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 500 natural alkaloids can be used for high throughput and high content screening;

A unique collection of 1639 compounds from food as medicine for high throughput and high content screening;

A collection of 1321 TCM monomers with anti-inflammatory activity or targeting molecular therapeutic targets in inflammation, a powerful tool for drug discovery and mechanism study;

A unique collection of 2928 compounds (TCM monomers) sourcing from traditional Chinese Medicines, is a powerful tool for drug discovery and research in mechanism;

A unique collection of 693 rare natural products, which can be used for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 5010 approved and clinical drugs for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 1796 annotated bioactive compounds with clear targets, suitable for phenotypic screening;

For your convenience, there are Diversity Sets of 5,000, 10,000, 15,000, and 20,000 compounds with no structure overlap.

A unique collection of 1220 compounds targeting ion channels for research in ion channels-related diseases and ion channel drug discovery;

A unique collection of 569 histone modification related compounds for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 815 compounds targeting cytokine signaling for high throughput screening and high content screening for drug discovery;